Back to Results
First PageMeta Content
GlaxoSmithKline / Fixed dose combination / Lamivudine / Organofluorides / ViiV Healthcare / Abacavir/lamivudine/zidovudine / Pfizer / Ondansetron / Novartis / Chemistry / Organic chemistry / Pharmacology


lab_safety_rep_rap_eval_etiq_06_2014-eng.xls
Add to Reading List

Document Date: 2014-07-18 14:38:25

Open Document

File Size: 61,44 KB

Share Result on Facebook
UPDATE